Galenica AG
GALE
주식 순위
#3269
Galenica AG stands as a leading healthcare services company, serving both the... Galenica AG stands as a leading healthcare services company, serving both the Swiss market and international clients. Its operations are organized into two principal divisions: "Products & Care" and "Logistics & IT." The "Products & Care" division oversees an extensive network of 520 pharmacies, comprising 368 directly owned outlets and 152 partner-affiliated pharmacies, operating under the recognized brand names of Amavita, Sun Store, and Coop Vitality. Beyond retail pharmacy services, this segment also provides medication for patients receiving home-based treatment. It is also responsible for the introduction and distribution of a diverse portfolio of consumer health, pharmaceutical, and parapharmaceutical products, in addition to offering vital marketing and sales support to its collaborators within the healthcare sector. The "Logistics & IT" division specializes in offering a suite of pre-wholesale services tailored for pharmaceutical and healthcare enterprises. These services encompass essential functions such as secure storage, efficient distribution, and comprehensive debt collection. Furthermore, this segment provides various logistics and information technology solutions, including a master data system specifically developed for the healthcare industry. It actively creates advanced management solutions relevant to the healthcare market and publishes technical information on pharmaceutical products in both printed and electronic formats, alongside delivering complete management tools for pharmacies. Founded in 1927, Galenica AG maintains its headquarters in Bern, Switzerland.
주가
$108.43
시가총액
$5.40B
변동 (1일)
1.19%
변동 (1년)
-3.89%
국가
CH
거래 Galenica AG (GALE)
카테고리
Healthcare
Galenica AG (GALE)의 수익
2026 기준 수익 TTM: 0
Galenica AG의 최신 재무 보고서에 따르면 회사의 현재 수익은 0입니다. 2026년에 회사는 0의 수익을 올렸으며 이는 2026년의 수익 0과 동일입니다. 이 페이지에 표시된 수익은 이자 및 세금 공제 전 수익으로, 즉 EBIT입니다.
Galenica AG의 수익 기록 (2014 ~ 2026)
연말 수익
| 연도 | 수익 | 변화 |
|---|---|---|
| 2025 | $280.22M | 17.95% |
| 2024 | $237.57M | 2.48% |
| 2023 | $231.81M | 9.67% |
| 2022 | $211.38M | -1.81% |
| 2021 | $215.28M | -5.25% |
| 2020 | $227.21M | 34.53% |
| 2019 | $168.90M | 49.81% |
| 2018 | $112.74M | -21.46% |
| 2017 | $143.55M | 40.14% |
| 2016 | $102.44M | 2.77% |
| 2015 | $99.67M | 1.17% |
| 2014 | $98.52M | 0.00% |
유사 기업 또는 경쟁사의 수익
| 회사 | 수익 | 수익 차이 | 국가 |
|---|---|---|---|
| $6.46B | - |
US
|
|
| - | - |
US
|
|
| $2.17B | - |
US
|
|
| - | - |
US
|
|
| $708.86M | - |
AU
|
